China Leads the Rush as Active Funds Surge
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
China ETFs absorbed $25.1B in net inflows in the past week. That is the single biggest geographic flow of the period, with a flow imbalance of 82.4, well above the threshold for strong buying pressure. The United States drew $20.8B, keeping it close behind. Over three months, the picture shifts: the US dominates at $286.6B, with China in third place at $57.9B. That is a sharp narrowing of the gap in just one week, suggesting China allocation is accelerating.
Geography Flows
Japan is the clearest reversal story. It pulled in $4.5B last week, with a flow imbalance of 88.1. Over three months, it posted an outflow of $21.8B, the only major geography in net negative territory over that window. Money that had been leaving Japan is now coming back fast. Taiwan also ran hot at $4.3B for the week, consistent with its three-month trend of $18.1B.
Europe flows remain modest. Developed Europe drew only $221M last week despite holding a positive three-month trend of $6.8B. Brazil flipped negative this week at minus $335M after a solid three-month inflow of $4.9B. India was virtually flat at plus $13M for the week, a soft reading against its three-month outflow of minus $766M. North America (ex-US) turned negative on the week at minus $452M.
Sector Rotation
Information Technology led all sectors with $2.6B in net inflows last week. Its flow imbalance of 59 is barely above neutral, however, reflecting heavy two-way trading across $8.5B in gross inflows versus $5.9B in gross outflows. Over three months, tech still leads at $11.8B, but the imbalance has fallen to 52.4, close to balanced. Financials attracted $884M last week, a sharp reversal from a three-month outflow of $9.5B. That is the biggest sector swing in the data.
Energy added $573M for the week and $2.8B over three months, with consistent positive flow. Health care drew $648M in the week. Materials was the week's worst sector at minus $637M, despite being marginally positive over three months at $785M. Industrials bled $373M this week and $1.5B over three months. Consumer Discretionary lost $364M. Real Estate was negative on the week but ran positive over three months at $1.9B.
Asset Class and Strategy
Equities dominate entirely. They pulled in $64.4B in net flows this week. Fixed Income added $4.2B. Over three months, the balance shifts meaningfully: equities at $536.5B versus fixed income at $285.7B. Bond funds are running at 53 cents of net flow for every dollar equities take in over three months, well above the one-week ratio of about six cents. That compression suggests some rotation toward safety is running below the weekly surface.
Commodities barely registered at $113M this week. Over three months they accumulated $32.7B, most of that likely driven by gold and energy exposure. Currency ETFs saw outflows of $1.1B this week after positive three-month flows of $6.9B.
On strategy, active funds are the standout. They took in $6.5B last week. Over three months they accumulated $159.3B, against $221.8B for passive vanilla funds. Active's three-month share is running at 72 cents per passive dollar, far above the weekly ratio of 15 cents. Growth strategies drew $3.6B this week and $20.3B over three months. Value added $1.2B on the week and $7.9B over three months. Momentum flipped negative over three months at minus $3.8B, though it was barely positive last week.
The overall tone is risk-on. Equities dominate across all timeframes, China is seeing accelerating demand, and active funds are capturing an outsized share of new money.
How this article was generated
- Generated
- 5 Nov 2026, 00:01
- Prompt version
- v1.0
- Data sources
- Institutional positioningORTEX Alpha signalsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.